← Back to Search

Radiation Therapy

Hypofractionated Intensity Modulated Radiotherapy (HIMRT) for Prostate Cancer

Phase 3
Waitlist Available
Led By Deborah A. Kuban, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8.5 years
Awards & highlights

Study Summary

This trial is testing two different types of radiation therapy for prostate cancer. One has more days at a lower dose, and one has fewer days at a higher dose. The safety of these treatments will be compared.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Conventional Radiotherapy (CIMRT) Versus Hypofractionated Radiotherapy (HIMRT)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hypofractionated Intensity Modulated Radiotherapy (HIMRT)Experimental Treatment1 Intervention
A total dose of 72 Gy will be delivered in 30 fractions to the PTV.
Group II: Intensity Modulated Radiotherapy (IMRT)Active Control1 Intervention
A total dose of 75.6 Gy will be delivered in 42 fractions to the planning target volume (PTV).

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,972 Previous Clinical Trials
1,787,096 Total Patients Enrolled
95 Trials studying Prostate Cancer
29,515 Patients Enrolled for Prostate Cancer
Deborah A. Kuban, MDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
1,051 Total Patients Enrolled
1 Trials studying Prostate Cancer
1,051 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation
2001. "A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00667888.
All > Prostate
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top